HPR174 Authorization and Financing Situation in Spain of the New Medicines and Indications Authorized by the European Commission in the Period 2021-2023
20240 citationsJournal Article
Field-Weighted Citation Impact: 0.00
HPR174 Authorization and Financing Situation in Spain of the New Medicines and Indications Authorized by the European Commission in the Period 2021-2023 | Researchclopedia